Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
PNNL’s Srinivas Katipamula and Nora Wang have received a Northwest Energy Efficiency Alliance award for contributing to the success of Seattle’s Building Tune-Up Accelerator Program.
PNNL scientists Richard (Dick) Smith and Ljiljana (Lili) Paša-Tolić are recognized by The Analytical Scientist in its 2019 Power List as two of 2019’s top 100 minds in analytical science.
A PNNL technology enables automated Economic Dispatch, which coordinates the use of energy in a manner that enhances distributed generation, efficiency, renewables, and grid reliability.
PNNL researchers Jianming Lian, Karanjit Kalsi, joint appointee Wei Zhang, and former PNNL intern Sen Li recently received a patent for a market mechanism consisting of novel bidding and clearing strategies.
